Breast Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 -20% Discount

1
Breast Cancer- Market Analysis, Global API
Manufacturers and Phase III Pipeline Assessment,
2014 -20 Discount
One-Stop Shop for Business Information
2
Summary
'Breast Cancer- Market Analysis, Global API
Manufacturers and Phase III Pipeline Assessment,
2014', report provides comprehensive insights
about phase III pipeline drugs and marketed drugs
across the indication. A key objective of the
report is to establish the understanding for API
Manufacturers for marketed and Phase III pipeline
drugs across the different countries and regions.
While the leading brands, companies and chemicals
are considered thoroughly, the report also
provides details on the drug master filings
across the US, Europe and Asia specifically China
and India. The research, analysis also presents
the global sales forecasts data till 2015. The
report is also giving insight about the patent
and exclusivity details of all the drugs across
the indication. Secondary sources information and
data has been collected from various printable
and non-printable sources like search engines,
News websites, Government Websites, Trade
Journals, White papers, Magazines, Trade
associations, Books, Industry Portals, Industry
Associations and access to vailable databases.
3
Scope A snapshot of the global Market
therapeutics scenario for Breast Cancer. A
review of the marketed products under
prescription for Breast Cancer, regulatory
information and marketing status. Coverage of
global patent coverage and detailed commentaries
on the US patent challenges. Graphical
representation of investigational products for
patent expiry and market exclusivities across
the globe. Product profiles for marketed
products for Breast Cancer with complete
description of mechanism of action, therapeutic
class, target, route(s) of administration and
chemical details. Coverage of API Manufacturers
for Breast Cancer drugs in the United States,
Europe and Asian Regions with location details.
Coverage of Regulatory filings in theUS, Europe,
and Asia specifically India and China for
Breast Cancer drugs.
4
Coverage of Route of Synthesis of Active
Pharmaceutical Ingredient associated with
Breast Cancer drugs. Coverage of Breast Cancer
Phase III pipeline products featuring sections on
product description, mechanism of action,
Chemical details and research development
progress. Coverage of the United States Drug
Master File (US DMF) available for Phase III
Pipeline Drugs. Key discontinued Marketed
products. Global Sales Figure from
2011-2015. Reasons to buy Evaluate the
marketing status and exclusivity details of
Breast Cancer key products to exploit
opportunities for generic drug development
opportunities.
5
Identify and understand important and diverse
types of therapeutics under Phase III
development for Breast Cancer. Design effective
counter-strategies to gain competitive advantage
by identifying the key patent expiry details
and exclusivity with respect to Disease.
API intelligence over marketed drugs for Breast
Cancer and gaining primary intelligence over
active ingredients manufacturers across the
globe. API intelligence over leading Phase III
pipeline drugs. Develop and design strategies
by identifying the API manufacturers for Phase
III pipeline products to enhance and expand
business potential and scope. Understanding the
scope of the Phase III Drugs with nil regulatory
filings. Understanding the chemical route of
synthesis of approved drugs for Breast
Cancer. Uncovering opportunities in the rapidly
growing the US markets.
6
Table Of Content

1. Indication Overview
2. Marketed Drugs Assessment
3. Marketed Details of Drugs by Application Type
4. Marketed Details of Drugs (NDA) by Marketing
   Status
5. Marketed Details of Drugs by Patent Expiration
   Timeline
6. The Active Pharmaceutical Ingredient (API)
   Manufacturers Assessment
7. The API Manufacturers by the United States Drug
   Master File (US DMF) Status
8. The API Manufacturers by the US DMF Status (Drug
   Specific)
9. The Active Pharmaceutical Ingredient (API)
   Manufacturers Assessment for Phase III Pipeline
   Drugs
10. The API Manufacturers by the US DMF Status (Drug
    Specific)
11. Drugs Market Data and Forecasted Sales Figures
    (2011-2015)
12. Marketed Drugs Information
13. Drugs Description

7

• To know more Breast Cancer- Market Analysis,
  Global API Manufacturers and Phase III Pipeline
  Assessment, 2014.

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com